5 Healthcare Dividend Stocks with Over 3% Yield

4. AbbVie Inc. (NYSE:ABBV)

Dividend Yield as of December 13: 4.46%

Number of Hedge Fund Holders: 81

AbbVie Inc. (NYSE:ABBV) made it to our list of the best healthcare dividend stocks, offering 49 years of consistent dividend growth, with a forward yield of 4.46% as of December 13. AbbVie Inc. (NYSE:ABBV) is one of the most popular healthcare stocks among the hedge funds, with 81 funds holding positions in the company in Q3, with stakes worth $4.14 billion. 

After its corporate spin off from Abbott Laboratories (NYSE:ABT) in 2013, AbbVie Inc. (NYSE:ABBV) has been a market leader in the pharmaceutical sector, offering medical products and clinical trials focused on immunology, oncology, neuroscience, eye care, and virology. 

Publishing its third quarter results on October 29,  AbbVie Inc. (NYSE:ABBV) posted an EPS of $3.33, beating estimates by $0.11. The quarterly revenue jumped 11.33% from the prior-year quarter to $14.34 billion, surpassing estimates by $43.28 million. 

On December 8, Mohit Bansal from Wells Fargo initiated coverage of AbbVie Inc. (NYSE:ABBV) with an Overweight rating and a $165 price target. The analyst thinks Humira, a signature AbbVie Inc. (NYSE:ABBV) product,  “overshadows the rest of the business”, but the business outside of Humira is growing at 10% revenue and 20% EPS CAGR.

Berkshire Hathaway is the largest AbbVie Inc. (NYSE:ABBV) stakeholder from the third quarter, with 14.3 million shares worth $1.55 billion.